Episode

Gout Journal Club

Podcast
Rheumnow Podcast
Published
Jul 8, 2026
Duration seconds
3446
Processing state
not_requested
Canonical source
https://rheumnow.podbean.com/e/gout-journal-club/
Audio
https://mcdn.podbean.com/mf/web/kbbfc2dgh9tyyznt/Gout_Journal_Club5zvu3.mp3
JSON
/v1/public/podcasts/rheumnow-podcast-587987/episodes/gout-journal-club
Markdown
/podcast/rheumnow-podcast-587987/gout-journal-club.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/rheumnow-podcast-587987/episodes/gout-journal-club/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/rheumnow-podcast-587987/gout-journal-club.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Gout Journal Club will examine two influential publications: 1. "Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients with Gout" (Cipolletta et al., JAMA Internal Medicine, 2026) and 2. "Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease"(Wang et al., JAMA Internal Medicine, 2025). Together, these studies provide new evidence supporting treat-to-target urate-lowering strategies and their potential impact on cardiovascular and renal outcomes. Panelists: Abhishek Abhishek, MD, PhD, MBBS, FRCP Zeqin Wen, MD Jie Wei, PhD Jack Cush, MD (moderator) Beyond reviewing the evidence, our expert panel will tackle the practical questions rheumatologists face every day.